EUVIMEDEUVIMED entdecken
Crossref

Botulinum Toxin Therapy for Spasmodic Dysphonia

Masamitsu Hyodo

The Japan Journal of Logopedics and Phoniatrics · 2026 · 67 (3) · 221-226

DOI: 10.5112/jjlp.67.221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Japan Journal of Logopedics and Phoniatrics, 2026. Verfasst von Masamitsu Hyodo.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Botulinum toxin (BT) injection into the intrinsic laryngeal muscles is considered the first-line treatment for spasmodic dysphonia (SD), both domestically and internationally. This therapy has the advantages of a high efficacy rate, minimal invasiveness, and a high safety profile. For adductor-type SD, BT injection through the cricothyroid membrane under electromyographic monitoring is the standard procedure. The treatment outcome is reported to be 90% to 95% effective, with effects lasting for 12 to 15 weeks. Transient breathy voice and liquid aspiration may occur as adverse effects after treatment; however, they reflect higher treatment efficacy. For the abductor type, the posterior cricothyroid muscle is the treatment target via an anterolateral cervical approach. However, owing to the difficulty of this approach, the efficacy rate is lower than that for the adductor type. BT therapy presents clinical issues, including fluctuating voice quality over time and the nonpermanent nature of the procedure's effects. Also, long-term treatment requires patients to undergo numerous hospital visits and incur large medical expenses. Therefore, surgical treatment options should be considered as an alternative.

Zitieren

APA

Hyodo, M. (2026). Botulinum Toxin Therapy for Spasmodic Dysphonia. The Japan Journal of Logopedics and Phoniatrics, 67(3), 221-226. https://doi.org/10.5112/jjlp.67.221

Vancouver

Hyodo M. Botulinum Toxin Therapy for Spasmodic Dysphonia. The Japan Journal of Logopedics and Phoniatrics. 2026;67(3):221-226. doi:10.5112/jjlp.67.221

BibTeX
@article{Hyodo2026,
  author = {Hyodo, Masamitsu},
  title = {Botulinum Toxin Therapy for Spasmodic Dysphonia},
  journal = {The Japan Journal of Logopedics and Phoniatrics},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {221--226},
  doi = {10.5112/jjlp.67.221}
}
Kostenlos starten →